RIGEL PHARMACEUTICALS INC Quarterly Unrecognized Tax Benefits in USD from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Rigel Pharmaceuticals Inc quarterly Unrecognized Tax Benefits history and growth rate from Q4 2010 to Q4 2023.
  • Rigel Pharmaceuticals Inc Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $8.67M, a 8% decline year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $8.67M -$754K -8% Dec 31, 2023 10-K 2024-03-05
Q4 2022 $9.43M +$240K +2.61% Dec 31, 2022 10-K 2024-03-05
Q4 2021 $9.19M +$285K +3.2% Dec 31, 2021 10-K 2024-03-05
Q4 2020 $8.9M +$543K +6.5% Dec 31, 2020 10-K 2024-03-05
Q4 2019 $8.36M $0 0% Dec 31, 2019 10-K 2023-03-07
Q4 2018 $8.36M +$928K +12.5% Dec 31, 2018 10-K 2022-03-01
Q4 2017 $7.43M +$527K +7.63% Dec 31, 2017 10-K 2020-02-27
Q4 2016 $6.9M -$10.4M -60% Dec 31, 2016 10-K 2019-02-28
Q4 2015 $17.3M +$11.9M +222% Dec 31, 2015 10-K 2018-03-06
Q4 2014 $5.37M +$373K +7.46% Dec 31, 2014 10-K 2017-03-07
Q4 2013 $5M +$701K +16.3% Dec 31, 2013 10-K 2016-03-08
Q4 2012 $4.3M +$2.8M +187% Dec 31, 2012 10-K 2015-03-03
Q4 2011 $1.5M $0 0% Dec 31, 2011 10-K 2014-03-04
Q4 2010 $1.5M Dec 31, 2010 10-K 2013-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.